diabetes increased blood sugar
Conditions
Interventions
All subjects meeting the inclusion and exclusion criteria in Group A will be
contacted and asked if they are interested in participating in a future
potential clinical study. If they have interest o
Sponsors
Janssen-Cilag
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * Man or woman of *18 years of age * Documented symptomatic atherosclerotic CV disease including a history of one of the following: * Stroke * Myocardial infarction * Hospitalized admission for unstable angina * Percutaneous coronary intervention (with or without stenting) * Peripheral revascularization (angioplasty or surgery) JNJ-28431754 Clinical Protocol 28431754PRD0001 5 Approved, Date: 29 March 2016 * Symptomatic with documented hemodynamically significant carotid or peripheral vascular disease
Exclusion criteria
Exclusion criteria: * History of T2DM, type 1 diabetes mellitus, latent autoimmune diabetes in adults (LADA), diabetic ketoacidosis * History of hereditary glucose-galactose malabsorption or primary renal glycosuria * History of use of a glucose lowering drug (other than short-term use during a hospitalization or for gestational diabetes; or subjects with a history of gestational diabetes may be included if at least 3 months has passed since the discontinuation of a glucose lowering drug)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| * support the assessment of the feasibility of conducting a clinical study in this population, and * identify subjects with CV disease and prediabetes who might have interest in participating in a future clinical study. | — |
Secondary
| Measure | Time frame |
|---|---|
| / | — |
Countries
Netherlands
Outcome results
None listed